Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
1.440
+0.110 (8.27%)
At close: Dec 11, 2025, 4:00 PM EST
1.430
-0.010 (-0.69%)
After-hours: Dec 11, 2025, 5:59 PM EST
Jaguar Health Market Cap
Jaguar Health has a market cap or net worth of $5.9 million as of December 11, 2025. Its market cap has decreased by -51.92% in one year.
Market Cap
5.90M
Enterprise Value
34.27M
1-Year Change
-51.92%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since October 5, 2018, Jaguar Health's market cap has decreased from $13.36M to $5.90M, a decrease of -55.83%. That is a compound annual growth rate of -10.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 5.45M | -54.27% |
| Dec 31, 2024 | 11.92M | 55.07% |
| Dec 29, 2023 | 7.68M | -41.52% |
| Dec 30, 2022 | 13.14M | -72.54% |
| Dec 31, 2021 | 47.85M | -44.06% |
| Dec 31, 2020 | 85.54M | 619.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 879.46B |
| Johnson & Johnson | 481.76B |
| AbbVie | 394.11B |
| UnitedHealth Group | 293.13B |
| AstraZeneca | 280.62B |
| Novartis AG | 254.28B |
| Merck & Co. | 240.48B |
| Thermo Fisher Scientific | 211.55B |